Analytica Bio Energy Corp Stock Price To Sales
Analytica Bio Energy Corp fundamentals help investors to digest information that contributes to Analytica Bio's financial success or failures. It also enables traders to predict the movement of Analytica Stock. The fundamental analysis module provides a way to measure Analytica Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Analytica Bio stock.
Analytica |
Analytica Bio Energy Corp Company Price To Sales Analysis
Analytica Bio's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Analytica Bio Price To Sales | 1.15 X |
Most of Analytica Bio's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Analytica Bio Energy Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Analytica Bio Energy Corp has a Price To Sales of 1.15 times. This is much higher than that of the sector and significantly higher than that of the Price To Sales industry. The price to sales for all United States stocks is notably lower than that of the firm.
Analytica Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Analytica Bio's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Analytica Bio could also be used in its relative valuation, which is a method of valuing Analytica Bio by comparing valuation metrics of similar companies.Analytica Bio is currently under evaluation in price to sales category among its peers.
Analytica Fundamentals
| Return On Equity | -16.3 | |||
| Return On Asset | -195.14 | |||
| Profit Margin | 311.56 % | |||
| Operating Margin | (49.59) % | |||
| Current Valuation | 536.46 K | |||
| Shares Outstanding | 29.18 M | |||
| Price To Earning | 0.35 X | |||
| Price To Sales | 1.15 X | |||
| Revenue | 202.5 K | |||
| Gross Profit | 62.91 K | |||
| EBITDA | (95.25 K) | |||
| Net Income | 630.92 K | |||
| Cash And Equivalents | 13.74 K | |||
| Total Debt | 316.75 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 0.31 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | 138.73 K | |||
| Earnings Per Share | 0.02 X | |||
| Beta | 3.32 | |||
| Market Capitalization | 233.44 K | |||
| Total Asset | 400 K | |||
| Retained Earnings | (4.68 M) | |||
| Working Capital | (556 K) | |||
| Current Asset | 249 K | |||
| Current Liabilities | 805 K | |||
| Z Score | -16.6 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Analytica Stock
If you are still planning to invest in Analytica Bio Energy check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Analytica Bio's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |